Search clinical trials for: relapsed multiple myeloma
Total 17271 results
-
Memorial Sloan Kettering Cancer CenterRecruitingLymphoma | Lymphoma, B-Cell | Multiple Myeloma | High-grade B-cell Lymphoma | Refractory B-Cell Lymphoma | DLBCL NOSUnited States
-
Chongqing Precision Biotech Co., LtdRecruitingMultiple Myeloma | Multiple Myeloma in Relapse | Neoplasm, Plasma CellChina
-
Weill Medical College of Cornell UniversityJanssen Scientific Affairs, LLCRecruitingAL Amyloidosis | Amyloid | Refractory AL AmyloidosisUnited States
-
Chongqing Precision Biotech Co., LtdRecruitingMultiple Myeloma | Multiple Myeloma in Relapse | Neoplasm, Plasma CellChina
-
Shanghai Changzheng HospitalGracell Biotechnology Shanghai Co., Ltd.RecruitingMultiple MyelomaChina
-
Rapa Therapeutics LLCMedical College of WisconsinRecruitingRelapsed, Refractory Multiple MyelomaUnited States
-
Kite, A Gilead CompanyArcellx, Inc.RecruitingRelapsed and Refractory Multiple MyelomaUnited States
-
GlaxoSmithKlineRecruitingMultiple MyelomaUnited States, Australia, France, Japan, Netherlands, Poland, Spain, Sweden, Greece, Canada, Korea, Republic of, Germany, Brazil, Israel, Mexico, Norway, Russian Federation
-
Hrain Biotechnology Co., Ltd.First Affiliated Hospital of Wenzhou Medical University; Shanghai Changzheng... and other collaboratorsRecruiting
-
Hrain Biotechnology Co., Ltd.Shanghai Changzheng HospitalRecruiting
-
Regeneron PharmaceuticalsRecruitingMultiple MyelomaBelgium, United States, Japan, Korea, Republic of, Germany, Spain, United Kingdom
-
Nanjing Legend Biotech Co.Janssen Research & Development, LLCRecruiting
-
Multiple Myeloma Research ConsortiumEli Lilly and Company; GlaxoSmithKline; AbbVie; Takeda; Genentech, Inc.; Celgene Corporation and other collaboratorsRecruitingRelapsed Refractory Multiple MyelomaUnited States
-
Canadian Myeloma Research GroupGlaxoSmithKlineRecruitingRelapsed and/or Refractory Multiple MyelomaCanada
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
UNC Lineberger Comprehensive Cancer CenterRecruitingImmune System Diseases | Multiple MyelomaUnited States
-
CelgeneRecruitingMultiple MyelomaUnited States, France, Germany, Spain, United Kingdom, Italy
-
University of LeedsTakeda; Cancer Research UKRecruitingMultiple MyelomaUnited Kingdom
-
Janssen Research & Development, LLCRecruitingHematological MalignanciesUnited States, Netherlands, Spain, Belgium
-
University of WashingtonRecruitingRefractory Multiple Myeloma | Plasma Cell Leukemia | Recurrent Multiple MyelomaUnited States
-
Hebei Senlang Biotechnology Inc., Ltd.Hebei Yanda Ludaopei Hospital; Beijing Lu Daopei HospitalRecruitingLymphoma | Leukemia | Multiple Myeloma of Bone (Diagnosis)China
-
CelgeneRecruitingMultiple MyelomaKorea, Republic of
-
Genentech, Inc.RecruitingMultiple MyelomaUnited States, Canada, Spain, Australia
-
The First Affiliated Hospital of Soochow UniversityRecruiting
-
Gruppo Italiano Malattie EMatologiche dell'AdultoRecruitingMultiple MyelomaItaly, United Kingdom
-
Janssen Research & Development, LLCRecruitingHematological MalignanciesUnited States, Netherlands, Spain, France, Sweden
-
OncotherapeuticsIncyte CorporationRecruitingMultiple MyelomaUnited States
-
Massachusetts General HospitalNovartis; Barbara Ann Karmanos Cancer Institute; Multiple Myeloma Research ConsortiumRecruitingA Study of Dabrafenib and/or Trametinib in Patients With Relapsed and/or Refractory Multiple MyelomaMultiple MyelomaUnited States
-
National Cancer Institute (NCI)RecruitingPlasmacytoma | Refractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingPreviously Treated Myelodysplastic Syndrome | Recurrent Adult Acute Myeloid Leukemia | Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | B-Cell Non-Hodgkin Lymphoma | Refractory T-Cell Non-Hodgkin Lymphoma | Refractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | Recurrent T-Cell... and other conditionsUnited States
-
Cellectar Biosciences, Inc.RecruitingMultiple Myeloma | Waldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Lymphoplasmacytic Lymphoma | Diffuse Large B Cell Lymphoma | Small Lymphocytic Lymphoma | Central Nervous System LymphomaUnited States, Australia, Czechia, Greece, Israel, Brazil, Finland, France, Spain, Turkey, United Kingdom
-
University of ChicagoNational Cancer Institute (NCI)RecruitingRefractory Multiple MyelomaUnited States
-
University of ChicagoNational Cancer Institute (NCI); Multiple Myeloma Research FoundationRecruitingMultiple MyelomaUnited States, Canada
-
Ottawa Hospital Research InstituteRecruiting
-
AbbVieJanssen Research & Development, LLCActive, not recruitingMultiple MyelomaUnited States, Australia, Canada, Denmark, France, Germany, Japan
-
AbbVieActive, not recruiting
-
SanofiCompletedPlasma Cell MyelomaFrance, Italy, Czechia, Greece, Spain, Canada, Australia, United States, Brazil, Hungary
-
Cartesian TherapeuticsActive, not recruitingMultiple Myeloma | Relapse Multiple MyelomaUnited States, Turkey
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, Israel
-
Ichnos Sciences SAGlenmark Pharmaceuticals S.A.CompletedRelapsed/Refractory Multiple MyelomaUnited States, France
-
GlaxoSmithKlineActive, not recruitingMultiple MyelomaUnited States, Australia, Spain, Bulgaria, Poland, Belgium, France, Germany, Italy, Hungary, United Kingdom, Greece, Russian Federation, Brazil, China, Korea, Republic of, Japan, Canada, Netherlands
-
OHSU Knight Cancer InstituteSanofi; Oregon Health and Science UniversityActive, not recruitingRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Abdullah KhanTerminatedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Plasmacytoma | Recurrent Plasma Cell Myeloma | Plasma Cell LeukemiaUnited States
-
Noah MerinTeva Branded Pharmaceutical Products R&D, Inc.; Miltenyi Biomedicine GmbHActive, not recruitingLymphoma | Multiple Myeloma | Hodgkin Lymphoma | Chronic Lymphocytic Leukemia | CLLUnited States
-
CelgeneWithdrawnMultiple MyelomaChina, Australia, United States, Argentina, Austria, Belgium, Brazil, Canada, Chile, Czechia, France, Germany, Greece, Hungary, India, Ireland, Italy, Japan, Korea, Republic of, Norway, Portugal, Romania, Spain, Sweden, Switzerland, Turkey, United Kingdom
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, Germany, Italy, Spain, Sweden, Japan
-
TakedaActive, not recruitingMultiple MyelomaUnited States, Spain, Canada, Korea, Republic of, Taiwan, China, Italy, Germany, Israel, France, United Kingdom, Greece, Japan, Norway, Puerto Rico, Turkey
-
Janssen Research & Development, LLCCompleted